These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30522964)

  • 81. Abdominal pain in Irritable Bowel Syndrome: a review of putative psychological, neural and neuro-immune mechanisms.
    Elsenbruch S
    Brain Behav Immun; 2011 Mar; 25(3):386-94. PubMed ID: 21094682
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Effect of inherent depression on chronic visceral hypersensitivity induced by colon acetate stimulation in neonatal rats].
    Liu YX; Zhang YS; Duan LP; Zhang L; Yang CQ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Apr; 47(2):289-94. PubMed ID: 25882947
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Preclinical Animal Studies of Intravesical Recombinant Human Proteoglycan 4 as a Novel Potential Therapy for Diseases Resulting From Increased Bladder Permeability.
    Greenwood-Van Meerveld B; Mohammadi E; Latorre R; Truitt ER; Jay GD; Sullivan BD; Schmidt TA; Smith N; Saunders D; Ziegler J; Lerner M; Hurst R; Towner RA
    Urology; 2018 Jun; 116():230.e1-230.e7. PubMed ID: 29545038
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Randomized clinical trial on the effect of a multispecies probiotic on visceroperception in hypersensitive IBS patients.
    Ludidi S; Jonkers DM; Koning CJ; Kruimel JW; Mulder L; van der Vaart IB; Conchillo JM; Masclee AA
    Neurogastroenterol Motil; 2014 May; 26(5):705-14. PubMed ID: 24588932
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Pioglitazone inhibits homocysteine-induced migration of vascular smooth muscle cells through a peroxisome proliferator-activated receptor gamma-independent mechanism.
    Li L; Gao PJ; Xi R; Wu CF; Zhu DL; Yan J; Lu GP
    Clin Exp Pharmacol Physiol; 2008 Dec; 35(12):1471-6. PubMed ID: 18759864
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Voltage-gated potassium channels in IB4-positive colonic sensory neurons mediate visceral hypersensitivity in the rat.
    Qian AH; Liu XQ; Yao WY; Wang HY; Sun J; Zhou L; Yuan YZ
    Am J Gastroenterol; 2009 Aug; 104(8):2014-27. PubMed ID: 19491827
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Effect of change in an inhibitory neurotransmitter of the myenteric plexus on the pathogenetic mechanism of irritable bowel syndrome subgroups in rat models.
    Xu JR; Luo JY; Shang L; Kong WM
    Chin J Dig Dis; 2006; 7(2):89-96. PubMed ID: 16643336
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Inhibitory effects of SKI3246, the rhizome extract of Atractylodes japonica, on visceral hypersensitivity in experimental irritable bowel syndrome rat models.
    Son HJ; Jung K; Park YH; Jeon HJ; Kang M; Ryu KH; Pyo SS; Eutamene H; Bueno L; Sun WS
    Arch Pharm Res; 2015; 38(5):642-9. PubMed ID: 25070763
    [TBL] [Abstract][Full Text] [Related]  

  • 89. DSP-6952, a novel 5-HT
    Mine Y; Itakura T; Oku S; Asada R; Shimizu I
    Eur J Pharmacol; 2018 May; 826():123-132. PubMed ID: 29428470
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Exendin-4, an analogue of glucagon-like peptide-1, attenuates hyperalgesia through serotonergic pathways in rats with neonatal colonic sensitivity.
    Yang Y; Cui X; Chen Y; Wang Y; Li X; Lin L; Zhang H
    J Physiol Pharmacol; 2014 Jun; 65(3):349-57. PubMed ID: 24930506
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Alleviation of Irritable Bowel Syndrome-Like Symptoms and Control of Gut and Brain Responses with Oral Administration of
    Chun E; Yoon S; Parveen A; Jin M
    Nutrients; 2018 Oct; 10(10):. PubMed ID: 30309025
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Spirocyclopiperazinium salt compound DXL-A-24 improves visceral sensation and gut microbiota in a rat model of irritable bowel syndrome.
    Xu Y; Yao R; Zhao W; Zhu J; Yao J; Zhang G; Liu D
    Heliyon; 2023 Jun; 9(6):e16544. PubMed ID: 37303540
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Visceral hypersensitivity in inflammatory bowel diseases and irritable bowel syndrome: The role of proteases.
    Ceuleers H; Van Spaendonk H; Hanning N; Heirbaut J; Lambeir AM; Joossens J; Augustyns K; De Man JG; De Meester I; De Winter BY
    World J Gastroenterol; 2016 Dec; 22(47):10275-10286. PubMed ID: 28058009
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Linaclotide Attenuates Visceral Organ Crosstalk: Role of Guanylate Cyclase-C Activation in Reversing Bladder-Colon Cross-Sensitization.
    Mohammadi EN; Ligon CO; Silos-Santiago A; Ge P; Kurtz C; Higgins C; Hannig G; Greenwood-Van Meerveld B
    J Pharmacol Exp Ther; 2018 Aug; 366(2):274-281. PubMed ID: 29784661
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Peroxisome proliferator activated receptor gamma (PPAR-γ) ligand pioglitazone regulated gene networks in term human primary trophoblast cells.
    El Dairi R; Huuskonen P; Pasanen M; Rysä J
    Reprod Toxicol; 2018 Oct; 81():99-107. PubMed ID: 30031879
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Environmental enrichment reverses stress-induced changes in the brain-gut axis to ameliorate chronic visceral and somatic hypersensitivity.
    Orock A; Johnson AC; Mohammadi E; Greenwood-Van Meerveld B
    Neurobiol Stress; 2024 Jan; 28():100590. PubMed ID: 38075024
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Pioglitazone increases VEGFR3 expression and promotes activation of M2 macrophages via the peroxisome proliferator‑activated receptor γ.
    Zhang C; Zhang Y; Zhang C; Liu Y; Liu Y; Xu G
    Mol Med Rep; 2019 Apr; 19(4):2740-2748. PubMed ID: 30816473
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Brain Neuropeptides, Neuroinflammation, and Irritable Bowel Syndrome.
    Ishioh M; Nozu T; Okumura T
    Digestion; 2024; 105(1):34-39. PubMed ID: 37673052
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Treatment with the synthetic PPARG ligand pioglitazone ameliorates early ovarian alterations induced by dehydroepiandrosterone in prepubertal rats.
    Velez LM; Abruzzese GA; Heber MF; Ferreira SR; Motta AB
    Pharmacol Rep; 2019 Feb; 71(1):96-104. PubMed ID: 30508725
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Central regulatory mechanisms of visceral sensation in response to colonic distension with special reference to brain orexin.
    Okumura T; Ishioh M; Nozu T
    Neuropeptides; 2021 Apr; 86():102129. PubMed ID: 33636498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.